Niercelcarcinoom
Naar schatting is nierkanker wereldwijd de tiende meest voorkomende vorm van kanker.
mei 1, 2026
The critical role of chronobiology in modern medicine – Prof Beuselinck
mei 1, 2026
The role of nuclear medicine in RCC – Prof Withofs
mei 1, 2026
Belgian fellow-led presentations – all
april 17, 2026
Immune-related neurological toxicities – Dr Van Wylick
april 17, 2026
How do we deal with irAE and dysimmunity populations who need ICI in Belgium – Prof Aspeslagh
april 17, 2026
Immunotherapy-Induced hypophysitis: diagnosis, challenges, and therapeutic strategies – Dr Martens
april 17, 2026
How to handle challenging TKI toxicities? – Prof Seront
april 17, 2026
Upcoming therapeutic advances – Prof Rottey
april 17, 2026
Belgian fellow-led present: HBOC germline mut. and efficacy of ICI (BEL-RCC2 study) – Dr Vrijders
april 17, 2026
Belgian fellow-led present: TKI-related tox. marker as therapy resp. predictor in mRCC – Dr Vermassen
april 17, 2026
Belgian fellow-led presentations: Optimal treatment of brain metastases in RCC – Dr Roodhooft
april 17, 2026
Belgian fellow-led presentations: Role of eosinophils in clear-cell renal cell carcinoma – Dr Gilon
april 15, 2026
nccRCC – understanding the new classification and guiding treatment decisions – Prof. Verbiest
april 15, 2026
Real cases, real strategies Masterclass in action: interactive case discussions – Prof. Gennigens, Prof. Martinez, Prof. Seront
april 15, 2026
The evolving role of biomarkers: from concept to clinical impact – Prof. Rottey
april 15, 2026
The pro's and con’s of adjuvant therapy – Prof. Gennigens & Prof. Beuselinck
april 15, 2026
Debulking surgery in metastatic RCC: benefits and limitations – Prof. Van Praet
april 15, 2026
Optimizing radiation therapy in RCC: Expert insights and best practices – Prof. Berghen
april 15, 2026
Current landscape of first-line treatment in mRCC – Dr. Carril
april 15, 2026
The debate on IO treatment duration: current evidence and future directions – Dr. Decruyenaere
april 15, 2026
2L and beyond: treatment strategies post IO/IO & IO/TKI – Dr. Gizzi
april 24, 2025
EAU 2025 Highlights – RCC
maart 7, 2025
ASCO GU 2025 Highlights – RCC
oktober 10, 2024
ESMO 2024 highlights – RCC
december 19, 2023
Prostaat fusiebiopsie brochure
oktober 24, 2023
BIJWERKINGEN – Gewichtsverlies
oktober 24, 2023
ZIEKTE EN BEHANDELING – Wat is immuuntherapie?
oktober 23, 2023
LEVENSSTIJL – Wat doet het met uw leven?
oktober 20, 2023
LEVENSSTIJL – Bewegen
oktober 20, 2023
LEVENSSTIJL – Voeding
oktober 20, 2023
BIJWERKINGEN – Hand-Voet-Huid reactie
oktober 20, 2023
BIJWERKINGEN – Misselijkheid
oktober 20, 2023
BIJWERKINGEN – Vermoeidheid
oktober 20, 2023
BIJWERKINGEN – Diarree
oktober 20, 2023
ZIEKTE EN BEHANDELING – Afspraak bij de oncoloog
oktober 20, 2023
ZIEKTE EN BEHANDELING – Wat is een TKI? (Tyrosine Kinase Inhibitor)
oktober 20, 2023
ZIEKTE EN BEHANDELING – Gevorderd niercelcarcinoom
oktober 20, 2023
ZIEKTE EN BEHANDELING – Wat is niercelcarcinoom?
september 26, 2023
Expert insights: Prof. Daniel Heng
september 26, 2023
Expert insights: Prof. Jens Bedke
september 25, 2023
Expert insights: Prof. Viktor Grünwald
november 24, 2022
BIJWERKINGEN – Hypertensie
juni 3, 2022
Expert insights: Prof. Monty Pal
juni 3, 2022
Expert insights: Prof. David Cella
